American Bio Medica Corp (ABMC) Financial Statements (2023 and Earlier)

Company Profile

Business Address 122 SMITH ROAD
KINDERHOOK, NY 12106
State of Incorp. NY
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2021
TTM
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 98411336156158
Cash and cash equivalents 98411336156158
Receivables 407370452348556672
Inventory, net of allowances, customer advances and progress billings 5368101,0191,4731,5821,746
Inventory 5368101,0191,4731,5821,746
Other undisclosed current assets 1394329979240
Total current assets: 1,1801,2271,6131,9542,3862,616
Noncurrent Assets
Operating lease, right-of-use asset 4173
Property, plant and equipment 576644718792824910
Intangible assets, net (including goodwill) 1081161231099367
Intangible assets, net (excluding goodwill) 1081161231099367
Deferred costs      190
Other noncurrent assets 212121212114
Other undisclosed noncurrent assets  (3) 1547 
Total noncurrent assets: 7468518629379851,181
TOTAL ASSETS: 1,9262,0782,4752,8913,3713,797
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 950990840808713740
Accounts payable 577652359374304373
Accrued liabilities 807775752525
Employee-related liabilities 107104278259299292
Taxes payable 164142115896737
Interest and dividends payable 221513111813
Debt 684388739533714852
Deferred compensation liability 138191167113  
Other liabilities 445220129366
Other undisclosed current liabilities 2056659117371
Total current liabilities: 2,0211,6871,8251,4771,5931,729
Noncurrent Liabilities
Long-term debt and lease obligation 4173  753945
Long-term debt, excluding current maturities     753945
Operating lease, liability 4173
Liabilities, other than long-term debt   719 162
Due to related parties      124
Other liabilities   719 38
Other undisclosed noncurrent liabilities 1,0791,108789772  
Total noncurrent liabilities: 1,1611,1817967917531,107
Total liabilities: 3,1822,8682,6212,2682,3462,836
Stockholders' equity
Stockholders' equity attributable to parent (1,256)(790)(146)6231,025961
Common stock 377327323298288260
Additional paid in capital 21,71721,43721,40421,17021,03720,656
Accumulated deficit (23,350)(22,554)(21,873)(20,845)(20,300)(19,955)
Total stockholders' equity: (1,256)(790)(146)6231,025961
TOTAL LIABILITIES AND EQUITY: 1,9262,0782,4752,8913,3713,797

Income Statement (P&L) ($ in thousands)

9/30/2021
TTM
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues 4,1473,6553,8724,9145,6096,317
Revenue, net4,9145,6096,317
Cost of revenue (2,909)(2,471)(2,584)(2,917)(3,119)(3,462)
Cost of goods and services sold    (2,917)(3,119)(3,462)
Gross profit: 1,2381,1841,2881,9972,4902,855
Operating expenses (1,859)(1,777)(2,050)(2,308)(2,747)(3,081)
Operating loss: (621)(593)(762)(311)(257)(226)
Nonoperating income (expense) (173)(93)(264)(234)(84)101
Other nonoperating income (expense) (173)(93)(264)(234)(84)102
Interest and debt expense (175)(265)(284)(272)(284)(206)
Other undisclosed income from continuing operations before equity method investments, income taxes 175265284272284 
Loss from continuing operations before income taxes: (794)(686)(1,026)(545)(341)(331)
Income tax expense (benefit) (2)5(2) (4)(2)
Net loss available to common stockholders, diluted: (796)(681)(1,028)(545)(345)(333)

Comprehensive Income ($ in thousands)

9/30/2021
TTM
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss: (796)(681)(1,028)(545)(345)(333)
Comprehensive loss, net of tax, attributable to parent: (796)(681)(1,028)(545)(345)(333)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: